An exploration for the superior PCOS treatment--berberine or metformin?

Reference
Design
Participants
- Berberine hydrochloride, 500 mg 3 times/day (n=31)
- Metformin, 500 mg 2 times/day for the first week, then 3 times/day for the remainder of the study (n=30)
- Placebo tablet 2 times/day (n=28)
Study parameters assessed
Key findings
Practice implications
In terms of the long-term health risks associated with PCOS, this study demonstrated the superiority of berberine versus metformin.
References
1. U.S. Department of Health and Human Services, National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development. Beyond Infertility: Polycystic Ovary Syndrome (PCOS). www.nichd.nih.gov/publications/pubs/upload/PCOS_booklet.pdf. Accessed Oct. 31, 2012.
2. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes. Metabolism. 2008 May;57(5):712-717.
3. Steriti R. Berberine for Diabetes Mellitus Type 2. Nat Med J. Oct 1, 2010. www.naturalmedicinejournal.com/article_content.asp?article=61. Accessed Oct 31, 2012.
4. Liu L, Yu YL, Yang JS, et al. Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study. Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):371-381.
5. Han J, Lin H, Huang W. Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med Sci Monit. 2011 Jul;17(7): 164-167.
6. Zhao L, Li W, Han F, et al. Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril. 2011 Jan;95(1):461-463
7. Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93:2559-2565.
8. Li K, Yao W, Zheng X, Liao K. Berberine promotes the development of atherosclerosis and foam cell formation by inducing scavenger receptor A expression in macrophage. Cell Res. 2009; 19(8):1006-1017.
9. Lee TS, Pan CC, Peng CC, Kou YR, Chen CY, Ching LC, Tsai TH, Chen SF, Lyu PC, Shyue SK. Anti-atherogenic effect of berberine on LXRalpha-ABCA1-dependent cholesterol efflux in macrophages.J Cell Biochem. 2010 Sep 1;111(1):104-110.
10. Guan S, Wang B, Li W, Guan J, Fang X. Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL. Am J Chin Med. 2010;38(6):1161-1169.
11. Wang Y, Huang Y, Lam KS, et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovasc Res. 2009 Jun 1;82(3):484-492.
12. Yin J, Xing H, Ye J. Efficacy of berberine in patients with Type 2 diabetes. Metabolism. 2008 May;57(5):712-717.
13. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993;63(4):201-208.